Resultados de la búsqueda 271-280 of 6112 for depression and anxiety

1. Cirugía - Ensayos clínicos - Mayo Clinic

   Scottsdale/Phoenix, Ariz. The main objective of the Brain Tumor Repository is to allow access to coded patient data by researchers both inside and outside of ...

2. Cirugía - Ensayos clínicos - Mayo Clinic

   Pre-operative Vs. Post-operative Radiosurgery For Metastatic Brain Tumors. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...

4. Cirugía - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to compare two types of surgery for the treatment of uterovaginal prolapse to determine which surgery works best from a ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This study aims to demonstrate acceptability and feasibility of the use of Distance Reiki therapy versus sham Reiki therapy among multiple myeloma patients.

7. Cirugía - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. The purpose of this study is to evaluate thymoma recurrence rates in patients who underwent thymectomy. 3D Ultrasound Imaging for Breast Cancer ...

8. Cirugía - Ensayos clínicos - Mayo Clinic

   Jacksonville, Fla. The purpose of this study is to evaluate the utility, safety, effectiveness, and cost of physical therapy on elective spine surgery patients.

9. Cirugía - Ensayos clínicos - Mayo Clinic

   -Collect data, images, from patients undergoing surgical treatment of hip disorders (we will not be collecting social security numbers to send to Washington ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...